Laura J. van’t Veer, PhD, discussed determining more accurate methods of treatment for patients with early- and late-state breast cancer based on advances in genetic testing, specifically the 70-gene prognostic signature.
Chelsea LoCascio
Advertisement
Articles by Chelsea LoCascio
Advertisement
Latest Updated Articles
Expert Discusses the Present and Future of Genetic Testing in Breast CancerPublished: November 2nd 2017 | Updated:
Advertisement
Advertisement
